Liver Histopathological Features Influencing HBeAg Seroconversion in Patients with HBeAg-positive Chronic Hepatitis B Treated with Pegylated Interferon α
Objective To investigate the efficiency of pegylated interferon α therapy for patients with HBeAg-positive chronic hepatitis B (CHB) and explore whether liver histopathological features and other factors might influence HBeAg seroconversion.
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Sciendo
2014-03-01
|
| Series: | Infection International |
| Subjects: | |
| Online Access: | http://www.degruyter.com/view/j/ii.2014.3.issue-1/ii-2017-0067/ii-2017-0067.xml?format=INT |